PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2018 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Pfizer (PFE) CEO: Currently Focused on Smaller Deals - Bloomberg
January 29, 2019 10:23 AM ESTPfizer (NYSE: PFE) CEO: Currently Focused on Smaller Deals - Bloomberg
Pfizer (PFE) Tops Q4 EPS by 1c, FY EPS Guidance Misses Consensus
January 29, 2019 6:46 AM ESTPfizer (NYSE: PFE) reported Q4 EPS of $0.64, $0.01 better than the analyst estimate of $0.63. Revenue for the quarter came in at $13.98 billion versus the consensus estimate of $13.91 billion.
GUIDANCE:
Pfizer sees FY2019 EPS of $2.82-$2.92, versus the consensus of $3.04. Pfizer sees... More
